Does Untreated Sleep Apnea in Ehlers-Danlos Patients Get Progressively Worse with Age?
Yes, untreated obstructive sleep apnea (OSA) in Ehlers-Danlos syndrome (EDS) patients likely worsens with age, following the same progressive pattern seen in the general OSA population, but with additional EDS-specific anatomical vulnerabilities that may accelerate this progression.
Evidence for Age-Related OSA Progression
The natural history of OSA demonstrates a clear trend toward worsening over time. Studies show significant increases in apnea-hypopnea index (AHI) over time, especially in males, obese individuals, and older patients 1. The Wisconsin Sleep Cohort Study and Cleveland Family Study revealed progressive increases in AHI particularly between ages 40-60 years, even independent of BMI changes 1. While spontaneous improvement cannot be expected, the data consistently show a trend toward worsening of sleep-disordered breathing over time 1.
EDS-Specific Considerations
In EDS patients specifically, the progression pattern appears to shift from flow limitation in younger patients to frank apneas and hypopneas with increasing age 2. This is particularly concerning because:
- All EDS patients evaluated in one study had sleep-disordered breathing on polysomnography 2
- The prevalence of OSA in EDS patients is 32% compared to only 6% in matched controls (OR 5.3,95% CI 2.5-11.2) 3
- EDS patients have a 4.43 times higher risk of OSA diagnosis compared to controls 4
Anatomical Vulnerabilities That Worsen Over Time
The genetic cartilage defects in EDS create structural predispositions that likely deteriorate with aging:
- Nasal-maxillary cartilaginous defects lead to increased nasal resistance 2
- Increased tissue laxity in the upper airway worsens pharyngeal collapsibility 2, 5
- Scoliosis and spinal abnormalities (affecting 15-86% of some EDS populations) compound respiratory compromise 6
These structural issues, combined with the general age-related progression of OSA seen in the population at large, suggest EDS patients face a dual burden: the natural worsening of OSA with age plus progressive deterioration of already-compromised connective tissue structures.
Clinical Implications of Progression
Untreated OSA in EDS is associated with:
- Excessive daytime sleepiness (median Epworth Sleepiness Scale 11 vs 7 in controls) 3
- Impaired quality of life across all dimensions 3
- More severely delayed developmental milestones in younger patients 6
- Increased cardiovascular risk, metabolic dysregulation, and mortality—the same complications seen in general OSA populations 7, 8
Age-Specific Patterns
- Pediatric EDS patients: 6.45% have diagnosed OSA, with higher rates of adenotonsillar surgeries 4
- Young adults: Predominantly show flow limitation on polysomnography 2
- Older adults: Transition to more apneas and hypopneas, though clinical complaints remain similar 2
- Elderly: Up to 70% of men and 56% of women in the general elderly population have OSA 8, suggesting EDS patients would have even higher rates
Critical Pitfalls
- Underdiagnosis is rampant: EDS patients presenting to medical clinics with symptoms of sleep-disordered breathing are rarely referred for evaluation 2
- Symptom attribution error: Fatigue and poor sleep are often attributed to EDS itself rather than investigating OSA as a treatable comorbidity
- Delayed diagnosis: The longer OSA remains untreated, the more time for cardiovascular and metabolic complications to develop 7, 9
Management Algorithm
All EDS patients should be screened for OSA regardless of age, with particular vigilance as they age:
- Baseline screening: Question all EDS patients about snoring, witnessed apneas, excessive daytime sleepiness, and nocturia 8
- Objective testing: Polysomnography is required for diagnosis and severity assessment 8, 9
- Treatment: CPAP remains first-line, though adherence can be challenging; hypoglossal nerve stimulation has shown success in CPAP-intolerant EDS patients 5
- Serial monitoring: Given the progressive nature, repeat polysomnography should be considered every few years or with symptom changes
The combination of EDS-related anatomical vulnerabilities and the natural age-related progression of OSA creates a compounding effect that makes early diagnosis and treatment imperative in this population.